Skip to main content
Caplight Logo









SleepRes, Inc.

SleepRes, Inc.

Private
Murfreesboro, TennesseeHealthcare & Life Scienceshttps://sleepres.com/

Last Round

Early Stage

VC

Jun 24, 2026

Total Funding Raised

$2.2M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

SleepRes, Inc. is a therapeutic devices company developing a platform to deliver CPAP therapy more comfortably while maintaining efficacy and minimizing side effects.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Keywords

obstructive sleep apneasleep apnea therapypositive airway pressure systemPAP systemCPAP devicemedical devicesleep techdynamic pressure deliveryconnected medical devicepatient monitoringDurable Medical EquipmentDMEprovider portalFDA 510(k) clearancepatient engagement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SleepRes, Inc. Comparables

Compare SleepRes, Inc. with similar companies based on industry and business-model similarity.

SleepRes, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Resvent Medical Technology Co., Ltd.
81%
Sefam Medical
79%
ResMed
74%

SleepRes, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCJun 24, 2026
SeedAug 9, 2024

Key People

Founding team and executive leadership

John Lipman

Chief Executive Officer

Executive Team

Bernie Hete

Chief Technology Officer

Executive Team

Craig Salazar

Chief Financial Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 30, 2026

    Grew 38% QoQ, from 16 to 22 employees.

  • Aug 21, 2026

    Monthly visitors increased 56% month-over-month.

SleepRes, Inc. Filings

Explore SEC and related filing metadata, where available.

SleepRes, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SleepRes, Inc.'s valuation, stock price, and market status.

Is SleepRes, Inc. a public or private company?

SleepRes, Inc. is a private company.

What is the current stock price of SleepRes, Inc.?

SleepRes, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is SleepRes, Inc. worth (valuation)?

Valuation information for SleepRes, Inc. is not publicly available.

Can I buy SleepRes, Inc. stock?

SleepRes, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SleepRes, Inc.'s last funding round?

SleepRes, Inc.'s most recent funding round was Early Stage VC on June 24, 2026.

Who are the main investors in SleepRes, Inc.?

Investor information for SleepRes, Inc. is not publicly disclosed.

Will SleepRes, Inc. IPO soon?

No public IPO plans have been announced for SleepRes, Inc..

How can I track SleepRes, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SleepRes, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMurfreesboro, Tennessee
Employee Range19
Year Founded2021
Last FundingJun 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?